MAX MAMONKIN

US FDA examined 22 cases of cancers in CAR-T probe -officials

CAR-T treatment, which the FDA said has been used for 27,000 individuals in the United States, generally involves extracting disease-fighting white blood cells known as T-cells from a patient, re-engineering them to attack cancer and infusing them back into the body.